CVE-2017-0076

Description

Hyper-V in Microsoft Windows Vista SP2; Windows Server 2008 SP2 and 2008 R2; Windows 7 SP1; Windows 8.1; Windows Server 2012 and R2; Windows 10, 1511, and 1607; and Windows Server 2016 allows guest OS users, running as virtual machines, to cause a denial of service via a crafted application, aka "Hyper-V Denial of Service Vulnerability." This vulnerability is different from those described in CVE-2017-0098, CVE-2017-0074, CVE-2017-0097, and CVE-2017-0099.

Category

5.4
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.65%
Vendor Advisory microsoft.com
Affected: Microsoft Corporation Hyper-V
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/96636 third party advisory vdb entry
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2017-0076 patch vendor advisory
http://www.securitytracker.com/id/1037999 vdb entry

Frequently Asked Questions

What is the severity of CVE-2017-0076?
CVE-2017-0076 has been scored as a medium severity vulnerability.
How to fix CVE-2017-0076?
To fix CVE-2017-0076, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-0076 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-0076 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-0076?
CVE-2017-0076 affects Microsoft Corporation Hyper-V.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.